Véronique Orian-Rousseau

Title: Innovations of Véronique Orian-Rousseau

Introduction

Véronique Orian-Rousseau is a prominent inventor based in Rittershofen, France. She has made significant contributions to the field of cancer treatment and infection control through her innovative research and development of cyclic peptides. With a total of 3 patents, her work has the potential to impact the medical community significantly.

Latest Patents

Her latest patents include "CD44v6-derived cyclic peptides for treating cancers and angiogenesis related diseases." This invention relates to compounds, pharmaceutical compositions, and methods for treating various forms of cancer and diseases associated with angiogenesis using cyclic peptides. Another notable patent is "CD44V6 peptides as inhibitors of bacterial infections," which outlines a method for treating infections by administering a peptide or a pharmaceutically acceptable salt of the peptide to individuals in need of treatment.

Career Highlights

Véronique has worked with esteemed organizations such as the Karlsruhe Institute of Technology and Amcure GmbH. Her experience in these institutions has allowed her to collaborate with leading experts in her field and contribute to groundbreaking research.

Collaborations

Some of her notable coworkers include Alexandra Matzke and Helmut Ponta. Their collaborative efforts have further advanced the research and development of innovative solutions in the medical field.

Conclusion

Véronique Orian-Rousseau's contributions to the field of medical innovation through her patents and collaborations highlight her as a key figure in the fight against cancer and bacterial infections. Her work continues to inspire future advancements in medical research and treatment.